Sukhtian Ghiath M.

CIK 00017174411 companyAMMAN, M2

SEC Profile

Transactions

Companies

Filings

CIK

0001717441

Recent Transactions

50 trades

Award
Outlook Therapeutics, Inc.$OTLK
Warrants (right to buy)
2025-05-27+8,571,428→ 8,571,428 total
Award
Outlook Therapeutics, Inc.$OTLK
Common Stock
2025-05-27$1.40/sh+4,285,714→ 13,552,359 total
Exercise/Conversion
Outlook Therapeutics, Inc.$OTLK
Warrants (right to buy)
2025-01-17−3,458,571→ 0 total
Exercise/Conversion
Outlook Therapeutics, Inc.$OTLK
Common Stock
2025-01-17$2.51/sh+3,458,571→ 9,266,645 total
Award
Outlook Therapeutics, Inc.$OTLK
Warrants (right to buy)
2025-01-17+3,458,571→ 3,458,571 total
Award
Outlook Therapeutics, Inc.$OTLK
Warrants (right to buy)
2025-01-17+3,458,571→ 3,458,571 total
Disposition to Issuer
Outlook Therapeutics, Inc.$OTLK
Warrants (right to buy)
2025-01-17−3,458,571→ 0 total
Award
Outlook Therapeutics, Inc.$OTLK
Warrants (right to buy)
2025-01-17+3,458,571→ 3,458,571 total
Award
Outlook Therapeutics, Inc.$OTLK
Common Stock
2024-03-18+2,305,714→ 5,808,074 total
Award
Outlook Therapeutics, Inc.$OTLK
Warrants (right to buy)
2024-03-18+3,458,571→ 3,458,571 total
Award
Outlook Therapeutics, Inc.$OTLK
Common Stock
2022-12-28$0.88/sh+14,230,418→ 70,047,204 total
Other
Outlook Therapeutics, Inc.$OTLK
Common Stock
2022-04-21+27,982,529→ 55,816,786 total
Other
Outlook Therapeutics, Inc.$OTLK
Common Stock
2022-02-01$1.25/sh+2,500,000→ 27,982,529 total
Purchase
Outlook Therapeutics, Inc.$OTLK
Common Stock
2021-11-29$1.25/sh+16,000,000→ 27,834,257 total
Award
Outlook Therapeutics, Inc.$OTLK
Common Stock
2021-02-10$1.00/sh+1,013,627→ 11,834,257 total
Purchase
Outlook Therapeutics, Inc.$OTLK
Common Stock
2021-02-02$1.00/sh+8,360,000→ 10,820,630 total
Exercise/Conversion
Outlook Therapeutics, Inc.$OTLK
Common Stock
2020-03-23+29,358,621→ 50,965,058 total
Exercise/Conversion
Outlook Therapeutics, Inc.$OTLK
Series A-1 Convertible Preferred Stock
2020-03-23−68,112→ 0 total
Disposition to Issuer
Outlook Therapeutics, Inc.$OTLK
Series A-1 Convertible Preferred Stock
2020-03-19−68,112→ 0 total
Award
Outlook Therapeutics, Inc.$OTLK
Series A-1 Convertible Preferred Stock
2020-03-19+68,112→ 68,112 total
Award
Outlook Therapeutics, Inc.$OTLK
Common Stock
2020-02-26$1.02/sh+2,460,630→ 2,460,630 total
Award
Outlook Therapeutics, Inc.$OTLK
Warrants
2020-02-26$0.13/sh+1,230,315→ 1,230,315 total
Exercise/Conversion
Outlook Therapeutics, Inc.$OTLK
Common Stock
2020-01-29$0.23/sh+4,657,852→ 21,606,437 total
Exercise/Conversion
Outlook Therapeutics, Inc.$OTLK
Warrant (Right to Buy)
2020-01-29−2,093,750→ 0 total
Exercise/Conversion
Outlook Therapeutics, Inc.$OTLK
Warrant (Right to Buy)
2020-01-29$1.00/sh−1,282,051→ 0 total
Exercise/Conversion
Outlook Therapeutics, Inc.$OTLK
Warrant (Right to Buy)
2020-01-29$1.00/sh−1,282,051→ 0 total
Award
Outlook Therapeutics, Inc.$OTLK
Warrant (Right to Buy)
2020-01-27$1.00/sh+1,282,051→ 1,282,051 total
Disposition to Issuer
Outlook Therapeutics, Inc.$OTLK
Warrant (Right to Buy)
2020-01-27$1.00/sh−1,282,051→ 0 total
Award
Outlook Therapeutics, Inc.$OTLK
Warrant (Right to Buy)
2020-01-27$1.00/sh+1,282,051→ 1,282,051 total
Disposition to Issuer
Outlook Therapeutics, Inc.$OTLK
Warrant (Right to Buy)
2020-01-27$1.00/sh−1,282,051→ 0 total
Award
Outlook Therapeutics, Inc.$OTLK
Warrant (Right to Buy)
2020-01-27+2,093,750→ 2,039,750 total
Disposition to Issuer
Outlook Therapeutics, Inc.$OTLK
Warrant (Right to Buy)
2020-01-27−2,093,750→ 0 total
Other
Outlook Therapeutics, Inc.$OTLK
Series A-1 Convertible Preferred Stock
2019-12-31+1,661→ 68,112 total
Exercise/Conversion
Outlook Therapeutics, Inc.$OTLK
Warrant (Right to Buy)
2019-12-23−3,636,364→ 0 total
Exercise/Conversion
Outlook Therapeutics, Inc.$OTLK
Common Stock
2019-12-23$0.23/sh+2,909,091→ 16,948,585 total
Other
Outlook Therapeutics, Inc.$OTLK
Series A-1 Convertible Preferred Stock
2019-09-30+1,620→ 66,451 total
Other
Outlook Therapeutics, Inc.$OTLK
Series A-1 Convertible Preferred Stock
2019-06-30+1,581→ 64,831 total
Exercise/Conversion
Outlook Therapeutics, Inc.$OTLK
Common Stock
2019-06-17+2,181,818→ 14,039,494 total
Exercise/Conversion
Outlook Therapeutics, Inc.$OTLK
Warrant (Right to Buy)
2019-06-17−3,636,364→ 0 total
Award
Outlook Therapeutics, Inc.$OTLK
Common Stock
2019-04-12$2.75/sh+3,636,364→ 11,857,676 total
Award
Outlook Therapeutics, Inc.$OTLK
Warrant (Right to Buy)
2019-04-12+3,636,364→ 3,636,364 total
Award
Outlook Therapeutics, Inc.$OTLK
Warrant (Right to Buy)
2019-04-12+3,636,364→ 3,636,364 total
Other
Outlook Therapeutics, Inc.$OTLK
Series A-1 Convertible Preferred Stock
2019-03-31+1,542→ 63,250 total
Award
Outlook Therapeutics, Inc.$OTLK
Series A Convertible Preferred Stock
2018-07-18+6,526→ 58,735 total
Award
Outlook Therapeutics, Inc.$OTLK
Series A-1 Convertible Preferred Stock
2018-07-18+58,735→ 58,735 total
Disposition to Issuer
Outlook Therapeutics, Inc.$OTLK
Series A Convertible Preferred Stock
2018-07-18−58,735→ 0 total
Conversion
Outlook Therapeutics, Inc.$OTLK
Series A Convertible Preferred Stock
2018-06-20−208,836→ 52,209 total
Conversion
Outlook Therapeutics, Inc.$OTLK
Common Stock
2018-06-20+31,572,617→ 44,327,383 total
Award
Outlook Therapeutics, Inc.$OTLK
Warrants
2018-06-08$0.13/sh+10,256,410→ 20,512,820 total
Award
Outlook Therapeutics, Inc.$OTLK
Common Stock
2018-06-08$0.97/sh+6,377,383→ 12,754,766 total

Companies

Outlook Therapeutics, Inc.
Director, 10% Owner
$OTLK

Recent Filings

Address

7TH CIRCLE, ZAHRAN ST. ZAHRAN PLAZA BUILDING, 4TH FLOOR

AMMAN, M2, 11844

View on SEC.gov